DEA could reclassify marijuana to a less restrictive category - a drug policy expert weighs the pros and cons
The DEA will move to reclassify marijuana from Schedule I to Schedule III, following President Biden's initiative, amidst significant political pushback.
DEA could reclassify marijuana to a less restrictive category - a drug policy expert weighs the pros and cons
The DEA will move to reclassify marijuana from Schedule I to Schedule III, following President Biden's initiative, amidst significant political pushback.
Weed for PTSD? Eager for Better Cannabis Science, F.D.A. Clears Study.
The FDA has authorized a clinical trial on marijuana's effectiveness for PTSD, marking a significant policy shift towards recognizing its therapeutic uses.